You are here

Article info

Article menu
Download PDFPDF
Multiple sclerosis
Research paper
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation

Authors

  • Bianca Weinstock-Guttman Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA Department of Neurology, State University of New York at Buffalo, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Jesper Hagemeier Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Katelyn S Kavak Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Vasu Saini Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Kara Patrick Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Deepa P Ramasamy Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Muhammad Nadeem Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Ellen Carl Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • David Hojnacki Jacobs Comprehensive MS Treatment and Research Center, University at Buffalo, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Robert Zivadinov Department of Neurology, State University of New York at Buffalo, Buffalo, New York, USA Department of Neurology, Buffalo Neuroimaging Analysis Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA MR Imaging Clinical Translational Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bianca Weinstock-Guttman, Jacobs MS Center for Treatment and Research, 100 High Street, Buffalo, NY 14203, USA; bw8{at}buffalo.edu
View Full Text

Citation

Weinstock-Guttman B, Hagemeier J, Kavak KS, et al
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation
Journal of Neurology, Neurosurgery & Psychiatry 2016;87:937-943.

Publication history

  • Received September 10, 2015
  • Revised December 8, 2015
  • Accepted December 9, 2015
  • First published January 18, 2016.
Online issue publication 
August 12, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/